Immuron Ltd Files 6-K Report
Ticker: IMRN · Form: 6-K · Filed: Nov 18, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, disclosure
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed a 6-K on Nov 18, 2024, with updates, but details are sparse in the header.
AI Summary
Immuron Limited filed a Form 6-K on November 18, 2024, reporting on announcements made during November 2024. The filing indicates the company is a foreign private issuer and does not furnish information under Rule 12g3-2(b). The specific content of the announcements is not detailed in this header information.
Why It Matters
This filing provides an update on Immuron Limited's corporate activities and disclosures for the month of November 2024, which may contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves as a notification of other disclosures, without immediate new financial or operational data presented in the header.
Key Players & Entities
- Immuron Limited (company) — Registrant
- 001-38104 (other) — Commission File Number
- 20241118 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information which the issuer has made or is required to make public pursuant to the laws of its home country or jurisdiction, or which it has filed or will file with a stock exchange on which its securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on November 18, 2024.
Is Immuron Limited a US-based company?
No, Immuron Limited is a foreign private issuer, with its principal executive office located in Carlton South, Victoria, Australia.
Does Immuron Limited file annual reports under Form 20-F?
Yes, the filing indicates that Immuron Limited files annual reports under cover of Form 20-F.
What is the SIC code for Immuron Limited?
The Standard Industrial Classification (SIC) code for Immuron Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 314 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2024-11-18 08:00:18
Filing Documents
- ea0221593-6k_immuron.htm (6-K) — 13KB
- ea022159301ex99-1_immuron.htm (EX-99.1) — 44KB
- ea022159301ex99-2_immuron.htm (EX-99.2) — 58KB
- ex99-1_001.jpg (GRAPHIC) — 19KB
- ex99-1_002.jpg (GRAPHIC) — 17KB
- ex99-1_003.jpg (GRAPHIC) — 19KB
- ex99-1_004.jpg (GRAPHIC) — 91KB
- ex99-1_005.jpg (GRAPHIC) — 622KB
- ex99-1_006.jpg (GRAPHIC) — 532KB
- ex99-1_007.jpg (GRAPHIC) — 532KB
- ex99-1_008.jpg (GRAPHIC) — 357KB
- ex99-1_009.jpg (GRAPHIC) — 471KB
- ex99-1_010.jpg (GRAPHIC) — 542KB
- ex99-1_011.jpg (GRAPHIC) — 681KB
- ex99-1_012.jpg (GRAPHIC) — 511KB
- ex99-1_013.jpg (GRAPHIC) — 434KB
- ex99-1_014.jpg (GRAPHIC) — 677KB
- ex99-1_015.jpg (GRAPHIC) — 251KB
- ex99-1_016.jpg (GRAPHIC) — 734KB
- ex99-2_001.jpg (GRAPHIC) — 18KB
- ex99-2_002.jpg (GRAPHIC) — 21KB
- ex99-2_003.jpg (GRAPHIC) — 8KB
- ex99-2_004.jpg (GRAPHIC) — 3KB
- 0001213900-24-099357.txt ( ) — 9121KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on November 18, 2024 titled: - “2024 AGM Presentation” - “Results of Meeting” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 2024 AGM Presentation 99.2 Results of Meeting 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: November 18, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3